Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Oncology|December 16, 2020
Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) DatabaseLiqing Zou, Tiantian Guo, Luxi Ye, et al.
Radiation Oncology (London, England)|December 28, 2018
Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinomaXiaofei Zhang, Xi Yang, Jianjiao Ni, et al.
BMC Cancer|February 22, 2022
Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first-line tyrosine kinase inhibitors: brain metastasis and de novo T790M mattersYa Zeng, Tiantian Guo, Yue Zhou, et al.
Radiation Oncology (London, England)|September 16, 2021
Sintilimab, stereotactic body radiotherapy and granulocyte-macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter, single-arm, phase II trialJianjiao Ni, Yue Zhou, Lin Wu, et al.
Therapeutic Advances in Medical Oncology|May 8, 2023
Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIsYa Zeng, Xi Su, Yang Zhao, et al.
Nature Communications|August 22, 2024
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trialJianjiao Ni, Xiaofei Wang, Lin Wu, et al.
Radiation Oncology (London, England)|March 15, 2019
Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analysesJianjiao Ni, Guodong Li, Xi Yang, et al.
Cancer Medicine|September 6, 2022
Low- dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancerShanshan Jiang, Yue Zhou, Liqing Zou, et al.
Medicine|August 28, 2015
Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine TumorsShunda Du, Jianjiao Ni, Linqian Weng, et al.
Annals of Translational Medicine|February 23, 2023
The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort studyZhiqin Zheng, Xun Yuan, Yue Zhou, et al.
Pageof 8